Shutterstock.comNEW DELHI: Shares of . traded 1.16 per cent up in Monday's trade at 10:15AM (IST). Around 23,680 shares changed hands on the counter.
The counter opened at Rs 433.4 and touched an intraday high and low of Rs 443.0 and Rs 433.4, respectively, in the session so far. The stock of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 730.0 and a 52-week low of Rs 429.3.
As per BSE, the total market cap of the Aurobindo Pharma Ltd. stood at Rs 25763.72 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 5796.56 crore for the quarter ended 30-Sep-2022, down 7.65 per cent from previous quarter's Rs 6276.54 crore and down 4.01 per cent from the year-ago quarter's Rs 6038.5 crore.
The net profit for latest quarter stood at Rs 409.45 crore, down 41.25 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Sep-2022, DIIs held 9.82 per cent stake in the firm, while foreign institutional investors held 20.71 per cent and the promoters 48.76 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 12.2 and a price-to-book ratio of 1.59. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
The counter opened at Rs 433.4 and touched an intraday high and low of Rs 443.0 and Rs 433.4, respectively, in the session so far. The stock of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 730.0 and a 52-week low of Rs 429.3.
As per BSE, the total market cap of the Aurobindo Pharma Ltd. stood at Rs 25763.72 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 5796.56 crore for the quarter ended 30-Sep-2022, down 7.65 per cent from previous quarter's Rs 6276.54 crore and down 4.01 per cent from the year-ago quarter's Rs 6038.5 crore.
The net profit for latest quarter stood at Rs 409.45 crore, down 41.25 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Sep-2022, DIIs held 9.82 per cent stake in the firm, while foreign institutional investors held 20.71 per cent and the promoters 48.76 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 12.2 and a price-to-book ratio of 1.59. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.